多西紫杉醇
医学
内科学
肿瘤科
打开标签
随机对照试验
化疗
作者
Caicun Zhou,Dingzhi Huang,Yun Fan,Xinmin Yu,Yunpeng Liu,Yongqian Shu,Zhiyong Ma,Ziping Wang,Ying Cheng,Jie Wang,Sheng Hu,Zhihua Liu,Elena Poddubskaya,Umut Dişel,А. Л. Акопов,Mikhail Dvorkin,Wenjuan Zheng,Yiyuan Ma,Yan Wang,Songzi Li
标识
DOI：10.1016/j.jtho.2022.09.217
摘要
Tislelizumab was found to have a significantly improved and long-term clinical benefit in OS versus docetaxel in pretreated patients with advanced NSCLC, regardless of PD-L1 expression.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
秋风
cdercder
aaaa
Nole
aa
蓝天
DW
独特元蝶
东方元语
谢雷XIELei
YY
aajhajkahna
xing_xing
嘻嘻哈哈
jy
OK
DOC_XIONG
嘉心糖
极限001
牧青
皖公网安备34019202002308
